Motilal Oswal reiterates that Ipca Labs remains well-positioned to deliver steady earnings growth, backed by strong domestic franchise and improving export momentum, while maintaining its Buy rating.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.